Some Cancer Hospitals' Quality Data Will Soon Be Public

Cheryl Clark, for HealthLeaders Media , August 21, 2014

By year's end, CMS intends to post quality measures for 11 major cancer centers that until now have been exempt from public reporting. But a coalition of those centers worries that the agency is focusing on the wrong measures.

Before year's end, history in cancer care quality will be made.

That's when Hospital Compare will begin to show how well 11 prominent hospitals that annually treat tens of thousands of cancer patients perform on five quality measures. Another measure will be reported the following year.


>>>Alliance of Dedicated Cancer Centers

That's not all.

The Centers for Medicare & Medicaid Services will require reporting for another 13 measures by FY 2017. While many of these measures resemble those now required for other hospitals, most specifically deal with healthcare services only patients with cancer might get.

The 11 major hospitals, which include MD Anderson, City of Hope, Dana-Farber, and Memorial Sloan Kettering, had been exempt from federal quality reporting required of 3,500 other major hospitals. But a provision of the Patient Protection and Affordable Care Act changes that.

That's big news because spending on cancer care is estimated to approach $184 billion a year by 2020. The disease affects nearly 15 million Americans and kills nearly 600,000 a year. CMS believes that since cancer care practices vary widely, payers and patients should know what they're paying for.

Most of the quality measures about to be reported were developed or tested by the American Society of Clinical Oncology and the American College of Surgeons' Commission on Cancer, which accredits some 1,500 of the 2,500 hospitals that treat U.S. cancer patients.

1 | 2 | 3 | 4 | 5

Comments are moderated. Please be patient.

1 comments on "Some Cancer Hospitals' Quality Data Will Soon Be Public"

J Kuriyan (8/27/2014 at 2:38 PM)
Ahh! Finally I can read an article without the massive and irrelevant ad blocking the entire page. Having lost multiple friends to cancer, and having been involved in their treatment in multiple locations, it is fairly easy to say that standards of treatment and outcome vary considerably. The one advice I have is that every health plan should insist on a second opinion for treatment from a reputable tertiary center like MDAnderson. It'll save money - avoiding useless treatments offered by local oncologists - and often save lives. I think we should encourage places like MDAnderson to post their own quality measures - and that should include, for example, cases where "suggestions of alternative protocols" that led to an improved outcome - as it did in my friend's experience.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2016 a division of BLR All rights reserved.